Tough economic and regulatory environments place increasing pressure on life sciences companies to justify the value of their innovations to consumers, payers and policymakers. To interpret these evolving market dynamics and the overall needs of the healthcare ecosystem, organizations need a trusted partner to help them both set a strategic direction and put the plan into action.

The combination of Huron and Pope Woodhead provides life sciences, biotech and healthcare companies with deep market and industry experience and an end-to-end market access solution. Pope Woodhead’s strength in market access strategy combined with Huron’s deep commercial expertise provides an integrated and agile partner and the right value based solutions, globally.